CIMFX
Price
$27.49
Change
+$0.09 (+0.33%)
Updated
Jun 2 closing price
Net Assets
146.54B
RIDFX
Price
$27.59
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
Interact to see
Advertisement

CIMFX vs RIDFX

Header iconCIMFX vs RIDFX Comparison
Open Charts CIMFX vs RIDFXBanner chart's image
CIMFX vs RIDFX Comparison Chart in %
View a ticker or compare two or three
VS
CIMFX vs. RIDFX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMFX is a Buy and RIDFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMFX (147B) and RIDFX (147B) have equal amount of cash in the bank . RIDFX (3.70) and CIMFX (3.59) have matching dividends . CIMFX was incepted earlier than RIDFX: CIMFX (24 years) vs RIDFX (24 years). CIMFX (0.68) is less costly to investors than RIDFX (0.30). CIMFX (65.00) and RIDFX (65.00) have comparable annual turnover. CIMFX (250) and RIDFX (250) have matching initial minimum investment requirements. RIDFX (9.24) and CIMFX (9.09) have marching annual gain over last year. CIMFX return over 5 years is better than : 25.83 vs. RIDFX (23.37).
CIMFXRIDFXCIMFX / RIDFX
Total Expense Ratio0.680.30227%
Annual Report Gross Expense Ratio0.680.30227%
Fund Existence24 years24 years-
Gain YTD6.0496.10099%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets147B147B100%
Annual Yield % from dividends3.593.7097%
Returns for 1 year9.099.2498%
Returns for 3 years36.7937.3698%
Returns for 5 years25.8323.37111%
Returns for 10 years84.4160.77139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLPSX25.30N/A
N/A
JPMorgan US Large Cap Core Plus I
MXERX6.57N/A
N/A
Empower S&P SmallCap 600® Index Instl
VSRDX19.18N/A
N/A
VALIC Company I U.S. Socially Rspnb
RYOIX79.12N/A
N/A
Rydex Biotechnology Inv
OIEPX26.16N/A
N/A
JPMorgan Equity Income R3